Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Burkitt Lymphoma × Transplantation Conditioning × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 2 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia 1 Hodgkin Disease 1 Hematologic Diseases 1 HIV Infections 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 146 Rituximab 76 fludarabine phosphate 66 Peripheral Blood Stem Cell Transplantation 66 Filgrastim 62 Etoposide 62 Methotrexate 52 Cytarabine 52 Whole-Body Irradiation 46 Vincristine 45 Mycophenolic Acid 45 Radiotherapy 41 Cyclosporine 39 Melphalan 35 Busulfan 35 Tacrolimus 34 Prednisone 34 Doxorubicin 33 Dexamethasone 33 Antilymphocyte Serum 32 fludarabine 29 blinatumomab 21 Methylprednisolone 21 Granulocyte Colony-Stimulating Factor 20 Carmustine 20 Cord Blood Stem Cell Transplantation 19 CT-P10 18 Inotuzumab Ozogamicin 16 Calcium Dobesilate 16 merphos 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01516593 2022-08-04

CARMEN

IRCCS San Raffaele

Phase 2 Completed

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡